[多动症儿童的医学治疗：关于法国市场上销售的哌甲酯新剂型]
[Medical treatments of hyperactive child: about the new pharmaceutical forms of methylphenidate marketed in France].
作者信息
Le Heuzey M-F, Vergnaud S, Mouren M-C
机构信息
Service de psychopathologie de l'enfant et de l'adolescent, hôpital Robert-Debré, 48, boulevard Sérurier, 75935 Paris cedex 19, France.
出版信息
Arch Pediatr. 2006 Jan;13(1):100-3. doi: 10.1016/j.arcped.2005.09.007. Epub 2005 Oct 18.
Multimodal treatment of hyperactive child includes psychostimulant medication, methylphenidate (MPH) marketed in France in its short-acting form since about ten years. We report our clinical experience about the first fifty methylphenidate responders who received one of the two sustained-release forms available since summer 2004, tablets of oros-methyphenidate (Concerta LP) or microgranule-filled capsules (Ritaline LP).
对多动儿童的多模式治疗包括使用精神振奋药物，自大约十年前以来，哌甲酯（MPH）以短效形式在法国上市。我们报告了关于首批五十名哌甲酯反应者的临床经验，这些患者自2004年夏季以来接受了两种缓释剂型之一的治疗，即奥罗哌甲酯片（专注达长效片）或微颗粒填充胶囊（利他林长效胶囊）。
Zotero 插件